Streetbeat News

Analyst Ratings

AVID

Northland Capital Markets analyst Nehal Chokshi has downgraded Avid Technology (NASDAQ:AVID) from Outperform to Market Perform.

Portfolio Pulse from richadhand@benzinga.com

August 10, 2023 | 1:32 pm

AZEK

B. Riley Securities analyst Alex Rygiel has maintained a 'Buy' rating on AZEK Co (NYSE:AZEK) and raised the price target from $30 to $42.

Portfolio Pulse from jenniferd'souza@benzinga.com

August 10, 2023 | 1:31 pm

NRDY

Goldman Sachs analyst Eric Sheridan has maintained a Neutral rating on Nerdy (NYSE:NRDY) and raised the price target from $3.75 to $5.

Portfolio Pulse from Benzinga Newsdesk

August 10, 2023 | 1:30 pm

AVID

B. Riley Securities has downgraded Avid Technology (NASDAQ:AVID) from Buy to Neutral and lowered the price target from $35 to $27.05. The downgrade was announced by analyst Josh Nichols.

Portfolio Pulse from richadhand@benzinga.com

August 10, 2023 | 1:30 pm

MGNI

B. Riley Securities analyst Daniel Day has maintained a 'Buy' rating on Magnite (NASDAQ:MGNI) but lowered the price target from $20 to $16.

Portfolio Pulse from jenniferd'souza@benzinga.com

August 10, 2023 | 1:29 pm

IFF

Goldman Sachs analyst Adam Samuelson has maintained a Neutral rating on Intl Flavors & Fragrances (IFF) and lowered the price target from $120 to $78.

Portfolio Pulse from Benzinga Newsdesk

August 10, 2023 | 1:29 pm

GDRX

Goldman Sachs analyst Eric Sheridan has maintained a Neutral rating on GoodRx Holdings (NASDAQ:GDRX) and raised the price target from $6.25 to $7.

Portfolio Pulse from Benzinga Newsdesk

August 10, 2023 | 1:28 pm

RMBL

DA Davidson analyst Michael Baker maintains a 'Buy' rating on RumbleON (NASDAQ:RMBL) but lowers the price target from $13 to $11.

Portfolio Pulse from jenniferd'souza@benzinga.com

August 10, 2023 | 1:28 pm

ILMN

Evercore ISI Group analyst Vijay Kumar has maintained an 'Outperform' rating on Illumina (NASDAQ:ILMN) and raised the price target from $235 to $240.

Portfolio Pulse from jenniferd'souza@benzinga.com

August 10, 2023 | 1:26 pm

LLY

Goldman Sachs analyst Chris Shibutani has maintained a Neutral rating on Eli Lilly (NYSE:LLY) and raised the price target from $385 to $470.

Portfolio Pulse from Benzinga Newsdesk

August 10, 2023 | 1:25 pm